Cargando…

Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes

BACKGROUND: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. AIM: To identify insulin resistance-associated proteins and metabolites which decrease...

Descripción completa

Detalles Bibliográficos
Autores principales: Jüllig, Mia, Yip, Shelley, Xu, Aimin, Smith, Greg, Middleditch, Martin, Booth, Michael, Babor, Richard, Beban, Grant, Murphy, Rinki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011803/
https://www.ncbi.nlm.nih.gov/pubmed/24800810
http://dx.doi.org/10.1371/journal.pone.0096489
_version_ 1782314847848890368
author Jüllig, Mia
Yip, Shelley
Xu, Aimin
Smith, Greg
Middleditch, Martin
Booth, Michael
Babor, Richard
Beban, Grant
Murphy, Rinki
author_facet Jüllig, Mia
Yip, Shelley
Xu, Aimin
Smith, Greg
Middleditch, Martin
Booth, Michael
Babor, Richard
Beban, Grant
Murphy, Rinki
author_sort Jüllig, Mia
collection PubMed
description BACKGROUND: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. AIM: To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission. METHODS: Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with trypsin and labeled with iTRAQ isobaric tags prior to liquid chromatography-tandem mass spectrometry analysis. Metabolomic analysis was performed using gas chromatography-mass spectrometry. The effect of the respective bariatric surgery on identified proteins and metabolites was evaluated using two-way analysis of variance and appropriate post-hoc tests. RESULTS: HOMA-IR improved, albeit not significantly, in both groups after surgery. Proteomic analysis yielded seven proteins which decreased significantly after GBP only, including Fetuin-A and Retinol binding protein 4, both previously linked to insulin resistance. Significant decrease in Fetuin-A and Retinol binding protein 4 after GBP was confirmed using ELISA and immunoassay. Metabolomic analysis identified significant decrease of citrate, proline, histidine and decanoic acid specifically after GBP. CONCLUSION: Greater early decrease was seen for Fetuin-A, Retinol binding protein 4, and several metabolites after GBP compared to SG, preceding significant weight loss. This may contribute to enhanced T2D remission observed following foregut bypass procedures.
format Online
Article
Text
id pubmed-4011803
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40118032014-05-09 Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes Jüllig, Mia Yip, Shelley Xu, Aimin Smith, Greg Middleditch, Martin Booth, Michael Babor, Richard Beban, Grant Murphy, Rinki PLoS One Research Article BACKGROUND: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. AIM: To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission. METHODS: Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with trypsin and labeled with iTRAQ isobaric tags prior to liquid chromatography-tandem mass spectrometry analysis. Metabolomic analysis was performed using gas chromatography-mass spectrometry. The effect of the respective bariatric surgery on identified proteins and metabolites was evaluated using two-way analysis of variance and appropriate post-hoc tests. RESULTS: HOMA-IR improved, albeit not significantly, in both groups after surgery. Proteomic analysis yielded seven proteins which decreased significantly after GBP only, including Fetuin-A and Retinol binding protein 4, both previously linked to insulin resistance. Significant decrease in Fetuin-A and Retinol binding protein 4 after GBP was confirmed using ELISA and immunoassay. Metabolomic analysis identified significant decrease of citrate, proline, histidine and decanoic acid specifically after GBP. CONCLUSION: Greater early decrease was seen for Fetuin-A, Retinol binding protein 4, and several metabolites after GBP compared to SG, preceding significant weight loss. This may contribute to enhanced T2D remission observed following foregut bypass procedures. Public Library of Science 2014-05-06 /pmc/articles/PMC4011803/ /pubmed/24800810 http://dx.doi.org/10.1371/journal.pone.0096489 Text en © 2014 Jüllig et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Jüllig, Mia
Yip, Shelley
Xu, Aimin
Smith, Greg
Middleditch, Martin
Booth, Michael
Babor, Richard
Beban, Grant
Murphy, Rinki
Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
title Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
title_full Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
title_fullStr Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
title_full_unstemmed Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
title_short Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
title_sort lower fetuin-a, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011803/
https://www.ncbi.nlm.nih.gov/pubmed/24800810
http://dx.doi.org/10.1371/journal.pone.0096489
work_keys_str_mv AT julligmia lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT yipshelley lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT xuaimin lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT smithgreg lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT middleditchmartin lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT boothmichael lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT baborrichard lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT bebangrant lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes
AT murphyrinki lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes